Antares Pharma, Inc.
(NASDAQ : ATRS)

( )
ATRS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DXCMDexCom, Inc. 1.33%386.878.2%$1052.58m
ABTAbbott Laboratories -2.22%89.440.8%$646.15m
BDXBecton, Dickinson & Co. -2.55%233.161.0%$577.08m
DHRDanaher Corp. 0.20%158.570.7%$550.68m
INOInovio Pharmaceuticals, Inc. -1.73%14.216.3%$528.50m
MDTMedtronic Plc 0.98%98.100.6%$522.56m
TMOThermo Fisher Scientific, Inc. 1.26%336.711.0%$515.57m
BSXBoston Scientific Corp. 0.78%36.191.1%$395.76m
ISRGIntuitive Surgical, Inc. 1.35%568.652.4%$348.86m
SYKStryker Corp. 1.90%189.661.3%$347.92m
ALGNAlign Technology, Inc. 1.71%247.906.4%$313.33m
WSTWest Pharmaceutical Services, Inc. -2.65%205.841.6%$272.78m
BAXBaxter International, Inc. -1.63%85.511.8%$224.06m
EWEdwards Lifesciences Corp. -0.75%217.181.2%$209.46m
ZBHZimmer Biomet Holdings, Inc. 2.67%126.691.7%$192.22m

Company Profile

Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.